Home » Topics » Regulatory

Regulatory
RSS

Tegsedi approved in the E.U. for the treatment of hATTR

July 12, 2018

Tegoprazan approved for the treatment of GERD in Korea

July 9, 2018

Trerief approved in Japan for additional indication

July 4, 2018

FDA approves Braftovi + Mektovi for unresectable or metastatic melanoma

June 28, 2018

FDA approves Zemdri for cUTI, but issues CRL for bloodstream infections

June 27, 2018

FDA approves Epidiolex for seizures associated with LGS and Dravet syndrome

June 26, 2018

FDA approves moxidectin to treat river blindness

June 14, 2018

Ganovo approved in China for hepatitis C

June 13, 2018

FDA approves Rituxan for moderate to severe pemphigus vulgaris

June 11, 2018

FDA approves pegfilgrastim biosimilar Fulphila

June 5, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...